Inventor · disambiguated record
Shulin Li
Also filed as: LI SHULIN
7 granted patents·13 pending applications·21 citations·filing 1998–2024
79Inventor score
Files withUNIV TEXAS6LI SHULIN3UNIV JOHNS HOPKINS2MAGNA SEATING RES & DEVELOPMENT CHONGQING CO LTD1UNIV LOUISIANA STATE1
Top patents by PatentIndex Score
20 records- 0184US11421010B2T cells expressing membrane-anchored IL-12 for the treatment of cancerUNIV TEXAS·Filed 2017·Granted Aug 23, 2022·4 cites·34 claims
- 0280US12280697B2Low-posture zero-gravity seat frame capable of being adjusted in multiple directionsMAGNA SEATING RES & DEVELOPMENT CHONGQING CO LTD·Filed 2023·Granted Apr 22, 2025·1 cites·10 claims
- 0373US11512141B2Fibrinogen-like protein 2 (FGL2) monoclonal antibodies and their use in cancer detection and treatmentUNIV TEXAS·Filed 2018·Granted Nov 29, 2022·1 cites·20 claims
- 0467US9657077B2Carcinoma homing peptide (CHP), its analogs, and methods of usingLI SHULIN·Filed 2012·Granted May 23, 2017·4 cites·12 claims
- 0564US10329353B2Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating tumor cellsUNIV TEXAS·Filed 2014·Granted Jun 25, 2019·2 cites·16 claims
- 0663US2024350586A1Chaperones as an autophagy receptors for clearances of protein aggregates and/or aggregation-prone proteinsUNIV TSINGHUA·Filed 2024·Application pending·0 cites
- 0763US2022380429A1T cells expressing membrane-anchored il-12 for the treatment of cancerUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0858US2009123467A1Polypeptide-Nucleic Acid Conjugate for Immunoprophylaxis or Immunotherapy for Neoplastic or Infectious DisordersUNIV JOHNS HOPKINS·Filed 2008·Application pending·0 cites
- 0954US2007212337A1Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disordersUNIV JOHNS HOPKINS·Filed 2007·Application pending·0 cites
- 1050US12330197B2Large-scale axle intelligent cross wedge rolling mill for rail transitUNIV TAIYUAN SCIENCE & TECH·Filed 2022·Granted Jun 17, 2025·0 cites·10 claims
- 1150US2017260246A1Carcinoma homing peptide (chp), its analogs, and methods of usingUNIV LOUISIANA STATE·Filed 2017·Application pending·0 cites
- 1249US2024049196A1Frame structure configuration method and apparatus, electronic device and computer-readable storage mediumZTE CORP·Filed 2021·Application pending·0 cites
- 1349US2006037088A1Gene expression levels as predictors of chemoradiation response of cancerLI SHULIN·Filed 2004·Application pending·0 cites
- 1448US2021393753A1Fgl2 neutraling cell therapy and methods of use thereofUNIV TEXAS·Filed 2019·Application pending·0 cites
- 1544US2022118015A1Modified il-12 t cell therapy for the treatment of cancerUNIV TEXAS·Filed 2020·Application pending·0 cites
- 1643US2002025578A1Formulations for electroporationVALENTIS INC·Filed 2001·Application pending·0 cites
- 1741US6181125B1Combination apparatus of a distribution transformer and switchesFiled 1998·Granted Jan 30, 2001·9 cites·5 claims
- 1839US2007280905A1Prognosis and Systemic Therapy for Treating MalignancyLI SHULIN·Filed 2007·Application pending·0 cites
- 1938US2003175717A1Apparatus and method for predicting treatment response of cancerFiled 2002·Application pending·0 cites
- 2028US2002102729A1Formulations for electroporationFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shulin Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →